The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Disease In-vitro Diagnostic Market Research Report 2024
Synopsis
The global Infectious Disease In-vitro Diagnostic market was valued at US$ 56 million in 2023 and is anticipated to reach US$ 85 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease In-vitro Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In-vitro Diagnostic.
Report Scope
The Infectious Disease In-vitro Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease In-vitro Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease In-vitro Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
BioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Segment by Type
Immunoassay
Molecular Diagnostics
Microbiology
Others
Segment by Application
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease In-vitro Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Infectious Disease In-vitro Diagnostic market was valued at US$ 56 million in 2023 and is anticipated to reach US$ 85 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease In-vitro Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In-vitro Diagnostic.
Report Scope
The Infectious Disease In-vitro Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease In-vitro Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease In-vitro Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
BioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Segment by Type
Immunoassay
Molecular Diagnostics
Microbiology
Others
Segment by Application
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease In-vitro Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoassay
1.2.3 Molecular Diagnostics
1.2.4 Microbiology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Infectious Disease In-vitro Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 COVID-19
1.3.3 MRSA
1.3.4 Clostridium Difficile
1.3.5 Respiratory Virus
1.3.6 TB and Drug-resistant TB
1.3.7 Chlamydia
1.3.8 Gonorrhea
1.3.9 HPV
1.3.10 HIV
1.3.11 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease In-vitro Diagnostic Market Perspective (2019-2030)
2.2 Infectious Disease In-vitro Diagnostic Growth Trends by Region
2.2.1 Global Infectious Disease In-vitro Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease In-vitro Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease In-vitro Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease In-vitro Diagnostic Market Dynamics
2.3.1 Infectious Disease In-vitro Diagnostic Industry Trends
2.3.2 Infectious Disease In-vitro Diagnostic Market Drivers
2.3.3 Infectious Disease In-vitro Diagnostic Market Challenges
2.3.4 Infectious Disease In-vitro Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease In-vitro Diagnostic Players by Revenue
3.1.1 Global Top Infectious Disease In-vitro Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease In-vitro Diagnostic Revenue
3.4 Global Infectious Disease In-vitro Diagnostic Market Concentration Ratio
3.4.1 Global Infectious Disease In-vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease In-vitro Diagnostic Revenue in 2023
3.5 Infectious Disease In-vitro Diagnostic Key Players Head office and Area Served
3.6 Key Players Infectious Disease In-vitro Diagnostic Product Solution and Service
3.7 Date of Enter into Infectious Disease In-vitro Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease In-vitro Diagnostic Breakdown Data by Type
4.1 Global Infectious Disease In-vitro Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Type (2025-2030)
5 Infectious Disease In-vitro Diagnostic Breakdown Data by Application
5.1 Global Infectious Disease In-vitro Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease In-vitro Diagnostic Market Size (2019-2030)
6.2 North America Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024)
6.4 North America Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease In-vitro Diagnostic Market Size (2019-2030)
7.2 Europe Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024)
7.4 Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease In-vitro Diagnostic Market Size (2019-2030)
9.2 Latin America Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Infectious Disease In-vitro Diagnostic Introduction
11.1.4 BD Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.1.5 BD Recent Development
11.2 BioMérieux SA
11.2.1 BioMérieux SA Company Detail
11.2.2 BioMérieux SA Business Overview
11.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Introduction
11.2.4 BioMérieux SA Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.2.5 BioMérieux SA Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Infectious Disease In-vitro Diagnostic Introduction
11.3.4 Abbott Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Quidel Corporation
11.4.1 Quidel Corporation Company Detail
11.4.2 Quidel Corporation Business Overview
11.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Introduction
11.4.4 Quidel Corporation Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.4.5 Quidel Corporation Recent Development
11.5 OraSure Technologies, Inc.
11.5.1 OraSure Technologies, Inc. Company Detail
11.5.2 OraSure Technologies, Inc. Business Overview
11.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Introduction
11.5.4 OraSure Technologies, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.5.5 OraSure Technologies, Inc. Recent Development
11.6 Hologic, Inc. (Gen Probe)
11.6.1 Hologic, Inc. (Gen Probe) Company Detail
11.6.2 Hologic, Inc. (Gen Probe) Business Overview
11.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Introduction
11.6.4 Hologic, Inc. (Gen Probe) Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.6.5 Hologic, Inc. (Gen Probe) Recent Development
11.7 Danaher
11.7.1 Danaher Company Detail
11.7.2 Danaher Business Overview
11.7.3 Danaher Infectious Disease In-vitro Diagnostic Introduction
11.7.4 Danaher Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.7.5 Danaher Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Detail
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Introduction
11.8.4 QIAGEN Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.8.5 QIAGEN Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche Infectious Disease In-vitro Diagnostic Introduction
11.9.4 Roche Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.9.5 Roche Recent Development
11.10 Siemens Healthineers AG
11.10.1 Siemens Healthineers AG Company Detail
11.10.2 Siemens Healthineers AG Business Overview
11.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Introduction
11.10.4 Siemens Healthineers AG Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.10.5 Siemens Healthineers AG Recent Development
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Bio-Rad Laboratories, Inc. Company Detail
11.11.2 Bio-Rad Laboratories, Inc. Business Overview
11.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Introduction
11.11.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024)
11.11.5 Bio-Rad Laboratories, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunoassay
Table 3. Key Players of Molecular Diagnostics
Table 4. Key Players of Microbiology
Table 5. Key Players of Others
Table 6. Global Infectious Disease In-vitro Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Infectious Disease In-vitro Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Infectious Disease In-vitro Diagnostic Market Share by Region (2019-2024)
Table 10. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Infectious Disease In-vitro Diagnostic Market Share by Region (2025-2030)
Table 12. Infectious Disease In-vitro Diagnostic Market Trends
Table 13. Infectious Disease In-vitro Diagnostic Market Drivers
Table 14. Infectious Disease In-vitro Diagnostic Market Challenges
Table 15. Infectious Disease In-vitro Diagnostic Market Restraints
Table 16. Global Infectious Disease In-vitro Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Infectious Disease In-vitro Diagnostic Market Share by Players (2019-2024)
Table 18. Global Top Infectious Disease In-vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2023)
Table 19. Ranking of Global Top Infectious Disease In-vitro Diagnostic Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Infectious Disease In-vitro Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Infectious Disease In-vitro Diagnostic Product Solution and Service
Table 23. Date of Enter into Infectious Disease In-vitro Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Disease In-vitro Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2019-2024)
Table 27. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2025-2030)
Table 29. Global Infectious Disease In-vitro Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Application (2019-2024)
Table 31. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Application (2025-2030)
Table 33. North America Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 48. BD Company Detail
Table 49. BD Business Overview
Table 50. BD Infectious Disease In-vitro Diagnostic Product
Table 51. BD Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 52. BD Recent Development
Table 53. BioMérieux SA Company Detail
Table 54. BioMérieux SA Business Overview
Table 55. BioMérieux SA Infectious Disease In-vitro Diagnostic Product
Table 56. BioMérieux SA Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 57. BioMérieux SA Recent Development
Table 58. Abbott Company Detail
Table 59. Abbott Business Overview
Table 60. Abbott Infectious Disease In-vitro Diagnostic Product
Table 61. Abbott Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Quidel Corporation Company Detail
Table 64. Quidel Corporation Business Overview
Table 65. Quidel Corporation Infectious Disease In-vitro Diagnostic Product
Table 66. Quidel Corporation Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 67. Quidel Corporation Recent Development
Table 68. OraSure Technologies, Inc. Company Detail
Table 69. OraSure Technologies, Inc. Business Overview
Table 70. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product
Table 71. OraSure Technologies, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 72. OraSure Technologies, Inc. Recent Development
Table 73. Hologic, Inc. (Gen Probe) Company Detail
Table 74. Hologic, Inc. (Gen Probe) Business Overview
Table 75. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product
Table 76. Hologic, Inc. (Gen Probe) Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 77. Hologic, Inc. (Gen Probe) Recent Development
Table 78. Danaher Company Detail
Table 79. Danaher Business Overview
Table 80. Danaher Infectious Disease In-vitro Diagnostic Product
Table 81. Danaher Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 82. Danaher Recent Development
Table 83. QIAGEN Company Detail
Table 84. QIAGEN Business Overview
Table 85. QIAGEN Infectious Disease In-vitro Diagnostic Product
Table 86. QIAGEN Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 87. QIAGEN Recent Development
Table 88. Roche Company Detail
Table 89. Roche Business Overview
Table 90. Roche Infectious Disease In-vitro Diagnostic Product
Table 91. Roche Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Siemens Healthineers AG Company Detail
Table 94. Siemens Healthineers AG Business Overview
Table 95. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product
Table 96. Siemens Healthineers AG Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 97. Siemens Healthineers AG Recent Development
Table 98. Bio-Rad Laboratories, Inc. Company Detail
Table 99. Bio-Rad Laboratories, Inc. Business Overview
Table 100. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product
Table 101. Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2019-2024) & (US$ Million)
Table 102. Bio-Rad Laboratories, Inc. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease In-vitro Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infectious Disease In-vitro Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Immunoassay Features
Figure 4. Molecular Diagnostics Features
Figure 5. Microbiology Features
Figure 6. Others Features
Figure 7. Global Infectious Disease In-vitro Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Infectious Disease In-vitro Diagnostic Market Share by Application: 2023 VS 2030
Figure 9. COVID-19 Case Studies
Figure 10. MRSA Case Studies
Figure 11. Clostridium Difficile Case Studies
Figure 12. Respiratory Virus Case Studies
Figure 13. TB and Drug-resistant TB Case Studies
Figure 14. Chlamydia Case Studies
Figure 15. Gonorrhea Case Studies
Figure 16. HPV Case Studies
Figure 17. HIV Case Studies
Figure 18. Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc) Case Studies
Figure 19. Infectious Disease In-vitro Diagnostic Report Years Considered
Figure 20. Global Infectious Disease In-vitro Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 21. Global Infectious Disease In-vitro Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 22. Global Infectious Disease In-vitro Diagnostic Market Share by Region: 2023 VS 2030
Figure 23. Global Infectious Disease In-vitro Diagnostic Market Share by Players in 2023
Figure 24. Global Top Infectious Disease In-vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2023)
Figure 25. The Top 10 and 5 Players Market Share by Infectious Disease In-vitro Diagnostic Revenue in 2023
Figure 26. North America Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. North America Infectious Disease In-vitro Diagnostic Market Share by Country (2019-2030)
Figure 28. United States Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Canada Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Infectious Disease In-vitro Diagnostic Market Share by Country (2019-2030)
Figure 32. Germany Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Share by Region (2019-2030)
Figure 40. China Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Japan Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Latin America Infectious Disease In-vitro Diagnostic Market Share by Country (2019-2030)
Figure 48. Mexico Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Brazil Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Share by Country (2019-2030)
Figure 52. Turkey Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. BD Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 55. BioMérieux SA Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 56. Abbott Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 57. Quidel Corporation Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 58. OraSure Technologies, Inc. Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 59. Hologic, Inc. (Gen Probe) Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 60. Danaher Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 61. QIAGEN Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 62. Roche Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 63. Siemens Healthineers AG Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 64. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
